151 related articles for article (PubMed ID: 34003132)
1. The Costs and Cardiovascular Benefits in Patients With Peripheral Artery Disease From a Fourth-Generation Synchronous Telehealth Program: Retrospective Cohort Study.
Lee JK; Hung CS; Huang CC; Chen YH; Wu HW; Chuang PY; Yu JY; Ho YL
J Med Internet Res; 2021 May; 23(5):e24346. PubMed ID: 34003132
[TBL] [Abstract][Full Text] [Related]
2. Costs and Cardiovascular Benefits of a Fourth-Generation Synchronous Telehealth Program on Mortality and Cardiovascular Outcomes for Patients With Atrial Fibrillation: Retrospective Cohort Study.
Chang HY; Wu HW; Hung CS; Chen YH; Huang CC; Yang LT; Hwang ST; Yu JY; Lee JK; Ho YL
J Med Internet Res; 2024 Jan; 26():e48748. PubMed ID: 38190237
[TBL] [Abstract][Full Text] [Related]
3. Use of the CHA2DS2-VASc Score for Risk Stratification of Hospital Admissions Among Patients With Cardiovascular Diseases Receiving a Fourth-Generation Synchronous Telehealth Program: Retrospective Cohort Study.
Lee JK; Hung CS; Huang CC; Chen YH; Chuang PY; Yu JY; Ho YL
J Med Internet Res; 2019 Jan; 21(1):e12790. PubMed ID: 30702437
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the cost-effectiveness and clinical outcomes of a fourth-generation synchronous telehealth program for the management of chronic cardiovascular disease.
Ho YL; Yu JY; Lin YH; Chen YH; Huang CC; Hsu TP; Chuang PY; Hung CS; Chen MF
J Med Internet Res; 2014 Jun; 16(6):e145. PubMed ID: 24915187
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial Disease.
Hussain MA; Al-Omran M; Mamdani M; Eisenberg N; Premji A; Saldanha L; Wang X; Verma S; Lindsay TF
JAMA Surg; 2016 Aug; 151(8):742-50. PubMed ID: 27050566
[TBL] [Abstract][Full Text] [Related]
6. Mortality Benefit of a Fourth-Generation Synchronous Telehealth Program for the Management of Chronic Cardiovascular Disease: A Longitudinal Study.
Hung CS; Yu JY; Lin YH; Chen YH; Huang CC; Lee JK; Chuang PY; Ho YL; Chen MF
J Med Internet Res; 2016 May; 18(5):e102. PubMed ID: 27177497
[TBL] [Abstract][Full Text] [Related]
7. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
[TBL] [Abstract][Full Text] [Related]
8. Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome.
Inohara T; Pieper K; Wojdyla DM; Patel MR; Jones WS; Tricoci P; Mahaffey KW; James SK; Alexander JH; Lopes RD; Wallentin L; Ohman EM; Roe MT; Vemulapalli S
Am Heart J; 2018 Jul; 201():25-32. PubMed ID: 29910052
[TBL] [Abstract][Full Text] [Related]
9. Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction.
Sandesara PB; Hammadah M; Samman-Tahhan A; Kelli HM; O'Neal WT
Clin Cardiol; 2017 Sep; 40(9):692-696. PubMed ID: 28444995
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcome and cost-effectiveness of a synchronous telehealth service for seniors and nonseniors with cardiovascular diseases: quasi-experimental study.
Chen YH; Lin YH; Hung CS; Huang CC; Yeih DF; Chuang PY; Ho YL; Chen MF
J Med Internet Res; 2013 Apr; 15(4):e87. PubMed ID: 23615318
[TBL] [Abstract][Full Text] [Related]
11. Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT.
Inglis SC; Bebchuk J; Al-Suhaim SA; Case J; Pfeffer MA; Solomon SD; Hou YR; Pitt B; Dargie HJ; Ford I; Kjekshus J; Zannad F; Dickstein K; McMurray JJ
Int J Cardiol; 2013 Sep; 168(2):1094-101. PubMed ID: 23194780
[TBL] [Abstract][Full Text] [Related]
12. Effect of Contract Compliance Rate to a Fourth-Generation Telehealth Program on the Risk of Hospitalization in Patients With Chronic Kidney Disease: Retrospective Cohort Study.
Hung CS; Lee J; Chen YH; Huang CC; Wu VC; Wu HW; Chuang PY; Ho YL
J Med Internet Res; 2018 Jan; 20(1):e23. PubMed ID: 29367185
[TBL] [Abstract][Full Text] [Related]
13. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.
Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR
JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395
[TBL] [Abstract][Full Text] [Related]
14. Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58.
Bonaca MP; Wiviott SD; Zelniker TA; Mosenzon O; Bhatt DL; Leiter LA; McGuire DK; Goodrich EL; De Mendonca Furtado RH; Wilding JPH; Cahn A; Gause-Nilsson IAM; Johanson P; Fredriksson M; Johansson PA; Langkilde AM; Raz I; Sabatine MS
Circulation; 2020 Aug; 142(8):734-747. PubMed ID: 32795086
[TBL] [Abstract][Full Text] [Related]
15. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
Bonaca MP; Bhatt DL; Storey RF; Steg PG; Cohen M; Kuder J; Goodrich E; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Dalby A; Špinar J; Aylward P; Corbalán R; Abola MTB; Jensen EC; Held P; Braunwald E; Sabatine MS
J Am Coll Cardiol; 2016 Jun; 67(23):2719-2728. PubMed ID: 27046162
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: a retrospective cohort study.
Zhao Q; Wang L; Kurlansky PA; Schein J; Baser O; Berger JS
BMC Cardiovasc Disord; 2019 Jan; 19(1):19. PubMed ID: 30646855
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in major adverse cardiovascular outcomes among aged over 60 year-old patients with atherosclerotic cardiovascular disease: A population-based longitudinal study in Taiwan.
Lee MK; Hsu PC; Tsai WC; Chen YC; Lee HH; Lee WH; Chu CY; Lee CS; Yen HW; Lin TH; Voon WC; Lai WT; Sheu SH; Su HM
Medicine (Baltimore); 2020 May; 99(19):e19912. PubMed ID: 32384435
[TBL] [Abstract][Full Text] [Related]
18. Peripheral arterial disease and atrial fibrillation and risk of stroke, heart failure hospitalization and cardiovascular death: A nationwide cohort study.
Lin YS; Tung TH; Wang J; Chen YF; Chen TH; Lin MS; Chi CC; Chen MC
Int J Cardiol; 2016 Jan; 203():204-11. PubMed ID: 26512838
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Synchronous Telehealth Services With a Digital Platform on Day-by-Day Home Blood Pressure Variability in Patients with Cardiovascular Diseases: Retrospective Cohort Study.
Chen YH; Hung CS; Huang CC; Lee JK; Yu JY; Ho YL
J Med Internet Res; 2022 Jan; 24(1):e22957. PubMed ID: 35006089
[TBL] [Abstract][Full Text] [Related]
20. Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease: A Subgroup Analysis of the PRODIGY Randomized Clinical Trial.
Franzone A; Piccolo R; Gargiulo G; Ariotti S; Marino M; Santucci A; Baldo A; Magnani G; Moschovitis A; Windecker S; Valgimigli M
JAMA Cardiol; 2016 Oct; 1(7):795-803. PubMed ID: 27572001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
